The upregulation of WNT5A is not only restricted to SSc, but is also observed in fibroblasts of patients with sclerodermatous chronic graft-versus-host disease (scl cGvHD) and idiopathic pulmonary fibrosis (IPF) (Figure 1, A–D). This evidence concerns the gene WNT5A and pulmonary fibrosis.